Executive Summary

Oct 2019
PROSPECTS
Topical treatments continue to gain in popularity by directly targeting problem

Topical antifungals and the smaller niche of topical allergy remedies/antihistamines are growing in popularity in Ireland as concerns increase amongst Irish consumers regarding oral medication, particularly amongst those consumers who struggle to swallow large pills. There is also a perception amongst consumers that directly targeting a specific area with a topical treatment may produce faster and more effective results.

Irish parents happy to invest in babies’ comfort with leading nappy rash treatments

Nappy (diaper) rash treatments continued to be a popular form of dermatologicals in Ireland in 2019, recording stable demand amongst parents. An ongoing increase in the average unit price, which is predicted to continue over the forecast period, will not be enough to deter Irish parents from investing in their babies’ comfort, particularly as strong economic growth is now leading to increasing disposable incomes.

Salon treatments offer competition to dermatologicals with alternative treatments

Salon treatments pose increasing competition to some dermatologicals in Ireland, as consumers seek expert advice on how best to address various conditions. With increasing disposable incomes, Irish consumers are investing in treating certain skin conditions with alternative methods where once they would have perceived these to be expensive; light therapy and non-invasive cosmetic surgery are two alternative treatments that are increasing in popularity.

COMPETITIVE LANDSCAPE
McNeil Healthcare retains narrow lead but suffers strong share loss

McNeil Healthcare (Ireland) Ltd retained a narrow lead over its closest competitor Bayer Ltd in 2019. Both are leading players in their respective categories with McNeil Healthcare dominating hair loss treatments with its Regaine line and haemorrhoid treatments with Anusol, while Bayer leads topical antifungals with Canesten and nappy (diaper) rash treatments with Bepanthen.

Zovirax continues to dominate cold sore treatments but McNeil offers alternative product

Zovirax from GSK Consumer Healthcare continued to dominate cold sore treatments, benefiting not only from strong brand loyalty and being synonymous with cold sore treatments but also the increasing popularity of the category in 2019. Consumers who suffer from cold sores want to trust that the treatment they choose to address this issue will work rapidly due to the associated embarrassment and discomfort caused by this virus.

Nizoral experiences change in national brand owner

Medicated shampoo Nizoral, which address dandruff issues, experienced a change in national distribution when new global brand owner STADA Arzneimittel AG moved it from McNeil Healthcare to Clonmel Healthcare Ltd, which also contributed to the negative performance by the former player in 2019. Nizorel was sold by former global brand owner Johnson & Johnson in 2018 to STADA Arzneimittel AG, with the latter attempting to strengthen its overall position within consumer health, and where it is already present in dermatologicals with Hedrin in antiparasitics/lice (head and body) treatments, Polytar in medicated shampoos and Caldease in nappy (diaper) rash treatments amongst others.

Want to find out more about this report?
Request more information
Why buy this report?

Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions.

Your Recently Viewed Reports

Dermatologicals in Ireland

Samples (FAQs about samples):

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Medicated Skin Care industry in Ireland with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Medicated Skin Care industry in Ireland, our research will save you time and money while empowering you to make informed, profitable decisions.

The Medicated Skin Care in Ireland market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Medicated Skin Care in Ireland?
  • What are the major brands in Ireland?
  • What are the most popular formats for acne treatments?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Dermatologicals in Ireland - Category analysis

HEADLINES

PROSPECTS

Topical treatments continue to gain in popularity by directly targeting problem
Irish parents happy to invest in babies’ comfort with leading nappy rash treatments
Salon treatments offer competition to dermatologicals with alternative treatments

COMPETITIVE LANDSCAPE

McNeil Healthcare retains narrow lead but suffers strong share loss
Zovirax continues to dominate cold sore treatments but McNeil offers alternative product
Nizoral experiences change in national brand owner

CATEGORY DATA

Table 1 Sales of Dermatologicals by Category: Value 2014-2019
Table 2 Sales of Dermatologicals by Category: % Value Growth 2014-2019
Table 3 NBO Company Shares of Dermatologicals: % Value 2015-2019
Table 4 LBN Brand Shares of Dermatologicals: % Value 2016-2019
Table 5 LBN Brand Shares of Hair Loss Treatments: % Value 2016-2019
Table 6 Forecast Sales of Dermatologicals by Category: Value 2019-2024
Table 7 Forecast Sales of Dermatologicals by Category: % Value Growth 2019-2024

Consumer Health in Ireland - Industry Overview

EXECUTIVE SUMMARY

Ongoing stable demand for consumer health in Ireland supported by polarised consumer groups
Growing interest in vegetarian and vegan lifestyles supports demand for alternative sources of protein
Global players continue to lead consumer health
Internet retailing continues to gain ground as distribution channel
Positive performance for consumer health predicted although several negative factors could impact demand for certain products

MARKET INDICATORS

Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2014-2019
Table 9 Life Expectancy at Birth 2014-2019

MARKET DATA

Table 10 Sales of Consumer Health by Category: Value 2014-2019
Table 11 Sales of Consumer Health by Category: % Value Growth 2014-2019
Table 12 NBO Company Shares of Consumer Health: % Value 2015-2019
Table 13 LBN Brand Shares of Consumer Health: % Value 2016-2019
Table 14 Penetration of Private Label in Consumer Health by Category: % Value 2014-2019
Table 15 Distribution of Consumer Health by Format: % Value 2014-2019
Table 16 Distribution of Consumer Health by Format and Category: % Value 2019
Table 17 Forecast Sales of Consumer Health by Category: Value 2019-2024
Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2019-2024

APPENDIX

OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
Summary 1 OTC: Switches 2018-2019

DEFINITIONS

SOURCES

Summary 2 Research Sources